Penn radiologist John Bruce Kneeland, MD, examines the mechanism of action of  T1-rho MRI, the modality’s sensitivity to early proteoglycan loss from the osteoarthritic knee, and its capacity to analyze the success or failure of cartilage interventions by comparison to standard MRI.